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Abstract
Background: Acute poisonings are common and are treated at different levels of the health care system. Since most 
fatal poisonings occur outside hospital, these must be included when studying characteristics of such deaths. The 
pattern of toxic agents differs between fatal and non-fatal poisonings. By including all poisoning episodes, cause-
fatality rates can be calculated.
Methods: Fatal and non-fatal acute poisonings in subjects aged ≥16 years in Oslo (428 198 inhabitants) were included 
consecutively in an observational multi-centre study including the ambulance services, the Oslo Emergency Ward 
(outpatient clinic), and hospitals, as well as medico-legal autopsies from 1st April 2003 to 31st March 2004. 
Characteristics of fatal poisonings were examined, and a comparison of toxic agents was made between fatal and non-
fatal acute poisoning.
Results: In Oslo, during the one-year period studied, 103 subjects aged ≥16 years died of acute poisoning. The annual 
mortality rate was 24 per 100 000. The male-female ratio was 2:1, and the mean age was 44 years (range 19-86 years). In 
92 cases (89%), death occurred outside hospital. The main toxic agents were opiates or opioids (65% of cases), followed 
by ethanol (9%), tricyclic anti-depressants (TCAs) (4%), benzodiazepines (4%), and zopiclone (4%). Seventy-one (69%) 
were evaluated as accidental deaths and 32 (31%) as suicides. In 70% of all cases, and in 34% of suicides, the deceased 
was classified as drug or alcohol dependent. When compared with the 2981 non-fatal acute poisonings registered 
during the study period, the case fatality rate was 3% (95% C.I., 0.03-0.04). Methanol, TCAs, and antihistamines had the 
highest case fatality rates; 33% (95% C.I., 0.008-0.91), 14% (95% C.I., 0.04-0.33), and 10% (95% C.I., 0.02-0.27), respectively.
Conclusions: Three per cent of all acute poisonings were fatal, and nine out of ten deaths by acute poisonings 
occurred outside hospital. Two-thirds were evaluated as accidental deaths. Although case fatality rates were highest for 
methanol, TCAs, and antihistamines, most deaths were caused by opiates or opioids.
Background
Deaths by acute poisoning are mainly suicides or conse-
quences of substance use disorders. The majority of
deaths attributed to substance use disorder are consid-
ered accidental, i.e. death was not the intended outcome
[1]. However, a post-mortem determination of the inten-
t i o n  b e h i n d  a  f a t a l  i n t a k e  i s  u n c e r t a i n .  S o m e  s u i c i d e s
might be classified as accidental deaths, and vice versa
[2]. Furthermore, self-destructiveness is a common fea-
ture among those with suicidal behaviour and among
those repeatedly treated for accidental overdoses [3]. This
may explain why the evaluated intention in repeated
acute poisonings often changes from one admission to
another [4]. Hence, the inclusion of all deaths by acute
poisoning will give a more complete picture of mortality
and toxic agents used among this group of people with
unnatural deaths.
The changing availability of drugs influences the pat-
tern of toxic agents in fatal poisonings [5-7]. During
recent decades there has been a shift in prescriptions
from tricyclic anti-depressants (TCAs) to newer selective
serotonin reuptake inhibitors (SSRIs) and other anti-
depressants, although the recent controversy regarding
suicide risk is still debated [8,9]. The implementation of
methadone maintenance treatment has led to an increase
in deaths related to methadone intake [7], but the magni-
tude of the increase varies between countries [1]. Regular
updates on the pattern of toxic agents used are therefore
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of interest, as it is important in the discussion of prescrip-
tion policy and treatment of drug addiction. Death certif-
icates seldom include additional agents according to the
Anatomical Therapeutic Chemical (ATC) classification
system [10], and the coding of ethanol poisoning is prob-
lematic in the International Classification of Diseases
(ICD) system. Important information regarding toxic pat-
terns is therefore lost if studies are based solely on death
certificates and mortality statistics [10,11]. Studies
designed to examine the patterns of both main and addi-
tional agents in acute poisonings are therefore necessary.
In order to describe the pattern of poisoning it would
be useful to compare the toxic agents used in fatal versus
non-fatal poisonings, and hence the relative influence of
each agent on mortality rates. Case fatality rates can be
calculated as long as all fatal poisonings in a defined area
are known, along with the number of diagnosed non-fatal
acute poisonings.
The aim of the present study was to describe the pat-
tern of drugs detected in fatal acute poisonings in Oslo
during one year, including deaths both in and outside
hospitals.
Methods
A c u t e  p o i s o n i n g s  i n  s u b j e c t s  a g e d  1 6  y e a r s  o r  o l d e r
occurring in Oslo were included consecutively in an
observational multicentre study from 1st April 2003 to
31st March 2004. This was a prospective study using a
standardized data collection form, and the cases were
included consecutively. The complete study involved the
four hospitals in Oslo that treat patients with acute poi-
soning, the Oslo Emergency Ward (outpatient clinic), the
ambulance service in Oslo, and the Institute of Forensic
Medicine, University of Oslo. The patients were included
on admission. All contacts were recorded, and each poi-
soning episode was traced through different levels of care
using of each patient's unique personal identification
number. This also included those found dead and sub-
jected to medico-legal examination. Thus, a complete
one-year picture of all patients in the capital of Norway
who were in contact with health care services because of
acute poisoning was obtained. The catchment area had a
total population of 521 886, of which 428 198 were older
than 16 years (1st January 2004). Data on fatal poisoning
is presented here. The intention behind the fatal intake,
the history of substance use disorder, and previous sui-
cide attempts were assessed. Furthermore, the main toxic
agents in fatal and non-fatal acute poisonings in the same
geographical area and period were compared, and case-
fatality rates were calculated. Epidemiological data on the
non-fatal poisonings has been presented previously
[12,13].
Data collection
The inclusion criterion for the present part of the study
was exposure to a toxic substance in an amount leading to
death in subjects ≥16 years, i.e. a primary diagnosis of
acute poisoning. Deaths both in and outside hospitals
were included. Furthermore, both deliberate acute poi-
sonings and accidental poisonings were included. Exclu-
sion criteria were chronic poisoning and admission to
hospital or the Institute of Forensic Medicine with
another primary diagnosis, such as trauma, even if intox-
ication (mostly from ethanol) was the underlying reason
for the accident.
Medico-legal autopsies were performed at the Institute
of Forensic Medicine, University of Oslo. The Institute of
Forensic Medicine examines all deaths due to poisoning,
according to Norwegian law. Forensic pathologists at the
Institute perform the autopsies. Police records are avail-
able if relevant. In all forensic cases, toxicological analy-
ses were performed at the Norwegian Institute of Public
Health, Division of Forensic Toxicology and Drug Abuse.
For deaths occurring in hospitals where a medico-legal
autopsy was not performed, physicians obtained data by
completing a standardized registration form based on
medical files. If the patient had been conscious during the
hospital stay, the form was completed based on a clinical
interview.
Classification of toxic agents
Toxic agents were recorded and classified as main or
additional agents. Toxicologists at the Institute of Foren-
sic Toxicology and the forensic pathologist did the deter-
mination of the toxic agents responsible for the death in
the fatal cases. However, for patients who survived, and
for fatal poisonings in hospital not subjected to medico-
legal autopsy, the treating physician made the determina-
tion of the toxic agents leading to hospitalization.
For all medico-legal autopsies, drug screening was per-
formed. The main toxic agent in fatal poisonings was
defined as the substance supposed to be the main con-
tributor to death. Toxicological analyses included a drug-
screening program. According to the Institute of Forensic
Toxicology's standard protocol, blood from the common
iliac vein was used. Alcohols (ethanol, methanol, isopro-
anol and aceton) were analysed with headspace gas chro-
matography (GC), and two different columns were used.
Immunological screening was used for amphetamines,
cannabis (tetrahydrocannabinol, THC), cocaine/benzo-
ylecognin, opiates and opioids, and positive results were
confirmed using GC-mass spectrometry (GC-MS). Liq-
uid chromatography single stage mass spectrometry (LC-
single MS) was used for benzodiazepines and their
metabolites, and for 63 of the most commonly encoun-
tered drugs within the given groups: analgesics, anti-Bjornaas et al. BMC Emergency Medicine 2010, 10:13
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depressants, neuroleptics, anti-epileptics, and others.
Confirmation tests used also LC-single MS, but with dif-
ferent extraction and separation columns. In addition,
carbon monoxide was analysed for. Other drugs were
analysed on request.
Heroin metabolizes quickly to morphine via 6-mono-
acetylmorphine (6-MAM). If 6-MAM is not detected in
blood or urine, it is not possible to tell from the analytical
results if heroin or morphine was the initial compound.
Therefore, these deaths were registered as heroin/mor-
phine deaths.
The main toxicological agent in fatal poisonings was
determined by the forensic pathologist.
For patients who survived, and for fatal poisonings in
hospital not subjected to medico-legal autopsy, the main
toxic agent was defined as the substance supposed to be
most toxic considering the amount taken. Other agents
were defined as additional agents. The evaluation was
made by the treating physician based on all available
information. A drug screen was not routinely performed
but was conducted if requested by the physician (e.g. eth-
anol and paracetamol in most cases). Information
obtained at the highest level of care was chosen if the
patient was treated at different health care levels, i.e. if
the patient was treated both by ambulance services and in
hospital, data from the hospital was used in further analy-
ses. For hospitalized patients, the mean blood alcohol
concentration was 1.77 % (range 0.2 - 6.2) if ethanol was
identified, and if it was found to be the main toxic agent,
the mean blood concentration was 2.26 % (range 0.2 -
6.2). For the ambulance service, blood concentration lev-
els were not available. In the Oslo Emergency Ward,
blood concentration levels were available to the physi-
cians evaluating the main and additional agents, but these
figures were not available to the researchers. For fatal poi-
sonings, the alcohol concentration levels were not avail-
able to the researchers, but they were available to the
forensic pathologist classifying the toxic agents for each
patient.
Evaluated intention and substance abuse
The intention behind the fatal poisoning was classified as
suicide or accidental death. Evaluation of intention was
based on all information available in each case, including
patients' own reported intentions, when known. Special
attention was given to letters confirming suicidal intent,
supposed intake of lethal doses of the toxic agent(s), or
other active procedures to ensure a lethal outcome. Infor-
mation from other sources such as ambulance personnel
and companions was also taken into consideration. In the
forensic cases, the evaluation of intention was according
to the assessment of the forensic pathologist. In fatal poi-
sonings not subjected to medico-legal autopsy, the
attending physician classified the intention.
Substance use disorders were classified according to the
ICD-10 criteria [14], i.e. drug dependence as for ethanol,
p r e s c r i p t i o n  d r u g s ,  o r  i l l e g a l  d r u g s .  O n e  c a t e g o ry  w a s
chosen in each case, but among those who were depen-
dent on illegal drugs, six patients fulfilled the criteria for
other substance use disorders as well: four as ethanol
dependent, and two as dependent on prescription drugs.
Statistics
The standardized registration forms were optically
scanned and processed using TeleForm Desktop version
9.1 (TeleForm, Verity Inc., Sunnyvale, California). Statis-
tics were analysed using SPSS, version 16.0 (SPSS, Chi-
cago, Illinois), except 95% confidence intervals for case
fatality rates, where NCSS version 2007 (NCSS, Kaysville,
Utah) was used. An independent samples t test was used
to compare continuous data, and χ2 tests were used to
compare categorical data.
Ethics
The study was carried out according to the Helsinki dec-
laration. Permission was obtained from the National Data
Inspectorate and the Regional Ethics Committee. The
links between patients' names and social security num-
bers and the study case numbers were stored by Statistics
Norway.
Results
During one year, 103 subjects aged 16 years or older died
of acute poisoning in Oslo, giving an annual mortality
rate of 24 per 100 000 for Oslo. Eleven subjects (11%)
were treated in hospital because of acute poisoning but
died in spite of treatment (Figure 1), of whom three were
medico-legally examined. In one of these cases, the death
Figure 1 Deaths by acute poisoning in Oslo during one year.
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was not registered as caused by acute poisoning at the
time of death. Eight people (8%) treated on scene by
ambulance services were declared dead on scene,
whereas 84 (82%) were declared dead on scene by physi-
cians outside hospital or ambulance services.
Sixty-nine (67%) of all deaths were males (Table 1). The
mean age was 44 years (range 19-86 years); 42 years
among males and 49 years among females (p = 0.025).
Ninety-three (90%) were originally from Norway. In eight
cases, the deceased had previously been treated by ambu-
lance services because of acute poisoning in the same
year. Two other people had been treated in hospital dur-
ing the same year, and one person had been treated both
by ambulance services and in hospital on different occa-
sions during the study period.
The place of death was at home (n = 53, 51%), other pri-
vate locations (n = 15, 15%), in hospitals (n = 11, 11%),
outdoors (n = 9, 9%), other institutions (n = 2, 2%), public
restroom (n = 1, 1%) and unknown (n = 13, 13%). Two
were psychiatric in-patients at the time of death; one of
these cases was evaluated as suicide, one as accidental
death.
Pattern of main toxic agents
Opiates or opioids were the most frequent main toxic
agents, accounting for 68 (66%) deaths (Table 2). Fifty-
two (50% of total poisonings) were heroin- or morphine-
related deaths, six (6%) were related to methadone, five
(5%) to codeine, and in four (4%), the specific compound
was unknown. Ethanol was the second most common
main toxic agent (n = 9, 9%). TCAs, benzodiazepines, and
zopiclone accounted for four (4%) fatal poisonings each.
Paracetamol was the main toxic agent in two (2%) of the
cases. In forty-five (44%) cases the drug had presumably
been taken orally, 47 (46%) subjects had injected the
drug, four (4%) had inhaled the drug, and in seven (7%)
cases, the method of administration was unknown.
Additional agents
Benzodiazepines were the most common additional
agents, found in 74 (72%) of the cases (Table 2). Ethanol
was second most common, with 18 cases (17%), followed
by amphetamines (16%), neuroleptics (15%), SSRIs (14%),
cannabis or tetrahydrocannabinol (THC) (13%), parac-
etamol (11%), opiates or opioids (10%), other anti-depres-
sants (8%), and TCAs (5%).
Intention
Thirty-two (31%) of the deaths were suicides, and 71
(69%) were accidental deaths (Table 1). Among females,
17 (50%) of deaths were evaluated as suicides, compared
with 15 (22%) among males (p = 0.010). Written suicide
Table 1: Characteristics of fatal poisonings in Oslo during one year.
Males
n = 69 (%)
Females
n = 34 (%)
Total
n = 103 (%)
Mean age 42 49 44
Country of origin
Norway 61 (88) 32 (94) 93 (90)
Other 5 (7) 3 (4) 6 (6)
Unknown 1 (3) 1 (3) 4 (4)
Suicide letter 3 (4) 1(3) 4 (4)
Previous suicide attempt during lifetime 9 (13) 6 (18) 15 (15)
Drug dependence
None 4 (6) 5 (15) 9 (9)
Ethanol 9 (13) 3 (9) 12 (12)
Prescription drugs 1 (1) 5 (15) 6 (6)
Illegal drugs 42 (61) 12 (35) 54 (52)
Unknown 13 (19) 9 (26) 22 (21)
Evaluated intention
Suicide 15 (22) 17 (50) 32 (31)
Accidental death 54 (78) 17 (50) 71 (69)Bjornaas et al. BMC Emergency Medicine 2010, 10:13
http://www.biomedcentral.com/1471-227X/10/13
Page 5 of 11
Table 2: Main and additional toxic agents in fatal poisonings in Oslo during one year.
Main agents Additional agents* Sum*
n = 103 (%) n = 103 (%) n = 103 (%)
Opiates/opioids 68 (66) 10 (10) 78 (76)
Morphine/heroin 52 (50) - 52 (50)
Methadone 6 (6) 5 (5) 11 (11)
Codeine 5 (5) - 5 (5)
Dextropropoxyphene 1 (1) 3 (3) 4 (4)
Unknown 4 (4) 2 (2) 6 (6)
Ethanol 9 (9) 18 (17) 27 (26)
Tricyclic antidepressants 4 (4) 5 (5) 9 (9)
Benzodiazepines 4 (4) 74 (72) 78 (76)
Flunitrazepam 1 (1) 15 (15) 16 (16)
Diazepam 3 (3) 35 (34) 37 (36)
Other - 24 (23) 24 (23)
Zopiclone 4 (4) 7 (7) 11 (11)
Antihistamines 3 (3) 4 (4) 7 (7)
Paracetamol 2 (2) 11 (11) 13 (13)
Carbon monoxide 2 (2) 4 (4) 6 (6)
Neuroleptics 2 (2) 15 (15) 17 (17)
Cocaine 1 (1) 2 (2) 3 (3)
Selective serotonin reuptake inhibitors 1 (1) 14 (14) 15 (15)
Anti-epileptics 1 (1) - 1 (1)
Methanol 1 (1) - 1 (1)
Carisoprodol 1 (1) 6 (6) 7 (7)
Amphetamines - 16 (16) 16 (16)
Cannabis/THC - 13 (13) 13 (13)
Other anti-depressants - 8 (8) 8 (8)
Other sedatives - 2 (2) 2 (2)
Salicylic acid - 1 (1) 1 (1)
Total 103 (100) 210 313
*More than one additional agent per patient was registered if appropriate.Bjornaas et al. BMC Emergency Medicine 2010, 10:13
http://www.biomedcentral.com/1471-227X/10/13
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letters were found in four (4%) of the cases, all were eval-
uated as certain suicide. There was information regarding
previous suicide attempts in 15 (15%) of the cases: nine
(13%) among males and six (17%) among females.
Substance use disorders
Seventy per cent of the deceased were diagnosed post-
mortem with a substance use disorder (Table 3). Fifty-
four (52%) were evaluated as illegal drug dependent: 42
(60%) of males and 12 (35%) of females. Ethanol depen-
dency was found among 12 (12%): nine (23%) of males
and three (35%) of females. Six people (6%) were depen-
dent on prescription drugs. Among those evaluated as
suicides, three were classified as illegal drug dependent
(9% of all suicides) (Table 3). Four were ethanol depen-
dent (13%), and four were dependent on prescription
drugs (13%). One-third (34%) of those who committed
suicide had substance use disorders.
Toxic agents according to intention and substance use 
disorder
Opiates or opioids were the most commonly found main
toxic agent in both suicides and accidental deaths, found
in 44% and 76% of the cases, respectively (Table 4). In the
remaining cases of suicide, a spectrum of toxic agents was
used. Ethanol was the second most common main toxic
agent in accidental deaths (11%).
Anti-depressants (SSRIs, TCAs, or others) were found
as the main or additional toxic agent in 28 (27%) of the
deaths: 15 (22%) of men, and 13 (38%) of women. Thirty-
one per cent of those who committed suicide had taken
anti-depressants (n = 10), as had 25% of those with acci-
dental death (n = 18). Among those who were alcohol
dependent, 42% (n = 5) had taken anti-depressants. Sev-
enteen per cent of illegal drug abusers had used anti-
depressants (n = 9), whereas 50% of those abusing pre-
scription drugs had used such agents (n = 3).
Toxic agents in fatal vs. non-fatal acute poisonings
During the study period, 2998 acute poisoning episodes
were registered in Oslo. Of these, 103 were fatal, of whom
one episode were recognized as result of fatal poisoning
only at the autopsy, and therefore not included in studies
presented earlier [4,12]. The percentage of deaths per
acute poisoning episode was 3% in total (95% C.I., 0.03-
0.04). Opiates or opioids were the main toxic agent in the
majority of the fatal poisonings, whereas ethanol, opiates
or opioids, and benzodiazepines dominated among those
who survived the acute poisoning episode (Table 5). The
case fatality rate was 0.07 or 7% for opiates or opioids
(95% C.I., 0.06-0.09) and 0.9% for ethanol (95% C.I.,
0.004-0.02). Acute poisonings caused by methanol,
TCAs, and antihistamines resulted most often in fatal
poisonings when the total number of such poisonings
was taken into account. Methanol poisoning was fatal in
33% of the cases (95% C.I., 0.008-0.91), TCAs in 14% (95%
C.I., 0.04-0.33), and antihistamines in 10% (95% C.I., 0.02-
0.27) of all registered poisoning episodes by these sub-
stances, respectively.
Discussion
Three per cent of all acute poisonings were fatal. Previous
studies of acute poisonings have focused on in-hospital
mortality [15,16], although a register-based study for the
whole of Norway found that 80% of deaths occurred out-
side hospital [11]. In the present study from Oslo, the
mortality rate was 24 per 100 000 inhabitants, whereas
the register-based study including all of Norway found a
lower mortality rate (10.8 per 100 000) [11]. This may
indicate a higher mortality rate in Oslo, an urban setting,
Table 3: Evaluated intention in fatal poisoning and history of substance use disorders prior to death.
Substance use disorder Suicide n (%) Accidental death n (%) Total n (%)
None 8 (25) 1 (1) 9 (9)
Drug dependence 11 (34) 61 (86) 72 (70)
Ethanol 4 (13) 8 (11) 12 (12)
Prescription drugs 4 (13) 2 (3) 6 (6)
Illegal drugs 3 (9) 51 (72) 54 (52)
Unknown 13 (41) 9 (13) 22 (21)
Total 32 (101) 71 (100) 103 (100)Bjornaas et al. BMC Emergency Medicine 2010, 10:13
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which usually has a larger population of drug addicts
compared with the average of the whole country, includ-
ing rural areas. However, it may also indicate that retro-
spective register-based studies tend to underestimate
mortality.
In the present study, the in-hospital mortality of 1.1%
was comparable to other studies [17]. However, focusing
solely on in-hospital mortality tends to underestimate
mortality rates, and in the present study, the relative
importance of drugs found in patients who died in hospi-
tals differed from those who died outside hospitals. Fur-
thermore, the pre-hospital treatment of acute poisonings
is substantial, and in Oslo, naloxone treatment is given by
paramedics on scene [18]. Therefore, hospital statistics
are not sufficiently comprehensive when discussing fatal
poisonings in the context of prescription policy and drug
toxicity.
Opiates or opioids were the main toxic agents in two-
thirds of all fatal poisonings during the study period, and
heroin or morphine accounted for the majority of these
deaths. When compared with the other Nordic countries,
Norway has been shown to have a higher percentage of
deaths caused by heroin or morphine: 72% vs. 10% in Fin-
land, 44% in Denmark, and 66% in Sweden in 2002 [1]. In
the 2002 study, the mortality rate for fatal overdoses, as
well as the absolute number of deaths, was also higher in
Norway than in the other Nordic countries [1]. The high
mortality rate is probably correlated to the higher per-
centage of opiate or opioid poisonings, because the
majority of drug addicts die of drug-related causes
[19,20], as also reflected by the present study.
Methadone was found in 6% of the cases in the present
study, which included both substance abusers and non-
abusers. However, the percentage was 15% in the study
Table 4: Evaluated intention and main toxic agents in fatal poisonings in Oslo during one year.
Main toxic agents Suicide n (%) Accidental death n (%) Total n (%)
Opiates/opioids 14 (44) 54 (76) 68 (66)
Ethanol 1 (3) 8 (11) 9 (9)
Benzodiazepines 3 (9) 1 (1) 4 (4)
Paracetamol 2 (6) - 2 (2)
Methanol - 1 (1) 1 (1)
Neuroleptics 2 (6) - 2 (2)
Cocaine - 1 (1) 1 (1)
Tricyclic antidepressants 2 (6) 2 (3) 4 (4)
Selective serotonin reuptake inhibitors - 1 (1) 1 (1)
Antihistamines 2 (6) 1 (1) 3 (3)
Zopiclone 2 (6) 2 (3) 4 (4)
Carisoprodol 1 (3) - 1 (1)
Anti-epileptics 1 (3) - 1 (1)
Carbon monoxide 2 (6) - 2 (2)
Total 32 (98) 71(98) 103 (101)Bjornaas et al. BMC Emergency Medicine 2010, 10:13
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Table 5: Comparison of main toxic agents between fatal and non-fatal acute poisonings during one year in Oslo.
Main agents in acute poisonings Case fatality rates
Fatal Non-fatal Fatal cases/all cases
n (%) n (%) 95% C.I.
>5% fatality rate Methanol 1 (1) 2 (0.1) 1/3 = 0.33 0.008-0.91
TCAs** 4 (4) 24 (0.8) 4/28 = 0.14 0.04-0.33
Antihistamines 3 (3) 27 (0.9) 3/30 = 0.10 0.02-0.27
Zopiclone 4 (4) 45 (2) 4/49 = 0.08 0.02-0.20
Opiates/opioids 68 (66) 847(28) 68/915 = 0.07 0.06-0.09
Carbon monoxide 2 (2) 31 (1) 2/33 = 0.06 0.007-0.20
<5% fatality rate Cocaine 1 (1) 23 (1) 1/24 = 0.04 0.001-0.21
Anti-epileptics 1 (1) 33 (1) 1/34 = 0.03 0.0007-0.15
SSRIs** 1 (1) 45 (2) 1/46 = 0.02 0.0005-0.11
Neuroleptics 2 (2) 79 (3) 2/81 = 0.02 0.003-0.09
Carisoprodol 1 (1) 57 (2) 1/58 = 0.02 0.0004-0.09
Paracetamol 2 (2) 142 (5) 2/144 = 0.01 0.002-0.05
Benzodiazepines 4 (4) 261 (9) 4/265 = 0.01 0.004-0.04
<1% fatality rate Ethanol 9 (9) 984 (33) 9/993 = 0.009 0.004-0.02
No fatalities Cannabis/THC - 2 (0.1) 0/2 = 0 0-0.84
Salicylate - 3 (0.1) 0/3 = 0 0-0.71
Ethylene glycol - 4 (0.1) 0/4 = 0 0-0.60
Lithium - 6 (0.2) 0/6 = 0 0-0.46
Ecstasy - 9 (0.3)) 0/9 = 0 0-0.34
Other sedatives - 14 (0.5) 0/14 = 0 0-0.23
Cardiovascular agents - 15 (0.5) 0/15 = 0 0-0.22
NSAIDs** - 16 (0.5) 0/16 = 0 0-0.21
Amphetamine - 53 (2) 0/53 = 0 0-0.07
GHB** - 97 (3) 0/97 = 0 0-0.04
Others - 78 (3) - -
Unknown* - 63 (2) - -
Total 103 (100) 2981 (100) 103/2998 = 0.03 0.03-0.04
The toxic agents are reported according to their case fatality rate.
*Cases treated by the ambulance services as acute poisonings, but where the toxic agent was unknown or not registered.
**TCAs: tricyclic antidepressants, SSRIs: selective serotonin reuptake inhibitors, GHB: gamma-hydroxybutyrate, NSAIDs: non-steroid anti-
inflammatory drugs
from 2002, including substance abusers from the entire
country. The figures are small and would therefore be
expected to vary over time. A reduction in heroin-associ-
ated deaths was followed by an increase in methadone-
associated deaths in Hamburg [7] and Denmark [1].
Interestingly, the study from Hamburg found that two-
thirds of all methadone deaths were drug addicts who had
never been in the methadone maintenance treatment
(MMT) program. However, information regarding their
MMT status was not available in the present study. The
relatively small percentage of methadone-associated
d e a t h s  c o m p a r e d  w i t h  t h e  r e l a t i v e l y  h i g h  n u m b e r  o fBjornaas et al. BMC Emergency Medicine 2010, 10:13
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patients in the MMT program in Norway (4319 patients,
of whom 699 were in Oslo [21], vs. 2100 in the whole of
Sweden [22] in 2003), is not sufficient to dissuade MMT.
Methanol and TCAs had the highest case fatality rate
during the study period. Methanol is known to be highly
toxic, and in a methanol-poisoning outbreak in Norway
from 2002 to 2004, a 29% mortality rate was found [23].
The methanol poisonings in the present study were part
of this outbreak, and the observed 33% deaths per poi-
soning episode is in accordance with results for the out-
break as a whole.
F o u r  f a t a l i t i e s  w i t h  T CA s  w e r e  f o u n d ,  a n d  o n e  w i t h
SSRIs. The emerging use of SSRIs has led to a recent con-
troversy regarding whether these drugs increase or
decrease suicide rates. However, SSRIs were suspected
twice as often as TCAs in non-fatal cases. This is in
accordance with previous findings suggesting that the
risk of non-fatal self-harm may be increased in SSRIs
[24], but TCAs are more toxic [8]. In meta-analyses of
randomized controlled trials, Wayne et al. found that
SSRIs might increase suicide ideation, but found no evi-
dence that suicide risk was increased [9]. Because of a
shift in prescription pattern, SSRIs are now more com-
monly used than older anti-depressants [5]. Therefore, it
would be expected that SSRIs be found more often than
TCAs in this study. However, only 26% of those who com-
mitted suicide had taken anti-depressants, supporting
studies suggesting that under-treatment of depression is a
greater problem than an eventual increased risk of suicide
by specific compounds [25]. The present finding of anti-
depressants in 25% of accidental deaths presumably
reflects their therapeutic use and is possibly an indicator
of depression. Furthermore, this illustrates the potential
problems encountered when evaluating the intended out-
come of an acute poisoning post-mortem.
Ethanol and benzodiazepines are important co-drugs in
acute poisonings, but were found to be the main toxic
agents in nine and four fatalities, respectively. However,
because these drugs are the most commonly found in
acute poisonings in Oslo [12], the percentage of deaths
per poisoning episode was low, about 1%. Ethanol was the
main toxic agent in 9% of all fatal poisonings and an addi-
tional agent in 17%. Enhanced respiratory depression is
important in multiple-drug poisonings, both with opioids
[1] and psychoactive drugs [8]. Benzodiazepines caused
4% of all fatal poisonings, in accordance with findings
from England, where benzodiazepines caused 3.8% of all
deaths caused by single-drug poisoning. However, 75% of
all deaths had benzodiazepines as the main or additional
drugs. Zopiclone is increasingly used as a sedative com-
pared with benzodiazepines, as the potential for drug
dependency is thought to be less evident. However, there
were 8% deaths per poisoning episode for zopiclone vs.
1% for benzodiazepines in the present study, although
others have concluded that the fatal toxicity was the same
for both sedatives [26]. Acute poisoning by zopiclone
mimics benzodiazepine poisoning clinically, and could
have been classified as such in the non-fatal cases. Fur-
thermore, case fatality rates were calculated for main
toxic agents only, but many clinicians might have consid-
ered zopiclone a less harmful drug and therefore an addi-
tional agent in many cases, which could be a possible
bias.
Paracetamol was the main agent in two fatalities but an
additional agent in 11. Combinations of paracetamol and
codeine were quite common. In such cases, the main
agent was thought to be paracetamol in hospitalized
patients, because of the potential for liver damage, and
codeine in forensic cases, because of presumed respira-
tory depression causing death before liver failure
occurred.
The proportion of hidden suicides among drug over-
doses has been debated, but studies find that the majority
of such events are accidental, not deliberate [2,27]. In a
study by Pfab et al., patients treated for drug overdose
were interviewed after awakening, and 9% reported a sui-
cidal intention [2]. The reliability of suicide statistics in
cases of acute poisonings in Norway was most recently
evaluated in 1985, and the proportion of possible hidden
suicides was found to be 10%, corresponding to the study
by Pfab et al. [28]. Since then, the autopsy rate has
declined, and only three out of 11 fatal poisonings in hos-
pital underwent a medico-legal autopsy in this study.
Therefore, due to the declining autopsy rate, the suicide
rate is probably underestimated in Norway today, and the
31% classified as suicides should be considered a mini-
mum.
Seventy per cent of the fatal cases were classified as
substance abusers, mostly of illegal drugs, emphasizing
the increased mortality rate among this patient group
[29]. Only 10 deaths were classified as non-abusers, of
which nine were evaluated as suicides. Of course, no
information regarding previous substance abuse would
make it more unlikely to consider the cause of death acci-
dental and vice versa. However, it is worth emphasizing
that 34% of those who committed suicide were classified
as abusers. This is in accordance with other studies indi-
cating substance abuse as the second most common pre-
cursor to suicide [30].
Strengths and limitations
The major strength of this study was the inclusion of all
acute poisonings in Oslo during one year. The inclusion
of all acute poisonings, both fatal and non-fatal, within a
defined geographical area made it possible to generalize
to the general population of the city of Oslo, thus mini-
mizing selection bias. The completeness of the inclusion
of patients in these types of studies can always be ques-Bjornaas et al. BMC Emergency Medicine 2010, 10:13
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tioned. However, we included patients at three levels of
healthcare in this multi-centre study, and transferrals
between these levels were common. This helped to make
the study more complete because each patient could have
been included in up to three treatment facilities during
each episode. Each poisoning episode was traced through
the system, thus making comparison between fatal and
non-fatal poisonings possible. We believe the numbers to
be as close to reality as possible, although there is still a
possibility that some cases might have been missed.
The major limitation was that extensive laboratory test-
ing to identify the toxic agents was conducted only for the
cases undergoing a medico-legal autopsy. Blood or urine
screening has only a limited value in the treatment of
acute poisonings as long as the treatment is mainly symp-
tomatic and guided by clinical signs or symptoms. There-
fore, the classification of main or additional agents in
non-fatal poisonings was based on a clinical evaluation
and some laboratory analyses, if appropriate. However,
for the hospitalized patients, a serum laboratory test for
the eight most common agents was performed, and this
showed a good sensitivity for the most common agents
[31]. Unlike the deceased, hospitalized patients could give
information about drug intake, and the need for extensive
testing was therefore not necessary for the diagnosis of
acute poisoning. Apart from serum ethanol concentra-
tions, serum paracetamol concentrations and other toxic
agents analysed on request (such as lithium), laboratory
tests would not give a reliable immediate answer. How-
ever, results from arterial blood gas and other clinical
parameters were available. The treatment of acute poi-
sonings is based on the clinical evaluation of the patient,
combined with routine laboratory testing [32]. Most
drugs identified in studies using more extensive labora-
tory testing were additional drugs, and finding them
would not have altered treatment [33-35]. We therefore
chose this clinical definition. As for the evaluation of
intention, no form or scale was used. This is how the fatal
and the non-fatal poisonings are evaluated in clinical
practice, and therefore a generalization about the general
population could be made. For case-fatality rates, only
main toxic agents were used. Some toxic agents, such as
benzodiazepines, tend to be classified as additional
agents in non-fatal cases, and this might be a possible bias
for the calculated case-fatality rates.
Further studies are needed to address the relative
importance of different toxic agents, especially related to
the availability of the drugs. Prescription pattern, prefera-
bly for each patient, would add important information
regarding anti-depressant treatment and whether the opi-
oids or benzodiazepines used were prescribed medica-
tion or acquired illegally.
Conclusions
Acute poisonings were fatal in 3% of the registered poi-
soning episodes in Oslo during one year, and victims were
either treated by the health care system or found dead
outside hospital. The majority died of opiate or opioid
poisoning, and seven out of 10 deceased were classified as
drug dependent. One-third were evaluated as suicides.
The great majority of deaths occurred outside hospitals.
When compared with non-fatal poisonings, methanol
and TCAs were most toxic, i.e. had the highest percent-
age of fatal cases. Both fatal and non-fatal poisonings
need to be included when discussing toxicity and drug
use patterns.
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